DRD2 haplotype is associated with dyskinesia induced by levodopa therapy in Parkinson’s disease patients (Q61648243)
Jump to navigation
Jump to search
scientific article published on 01 November 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | DRD2 haplotype is associated with dyskinesia induced by levodopa therapy in Parkinson’s disease patients |
scientific article published on 01 November 2012 |
Statements
DRD2 haplotype is associated with dyskinesia induced by levodopa therapy in Parkinson's disease patients (English)
Mariana Rieck
Thaís L Monte
Carolina Lm Francisconi
Paulo Tb Fagundes
1 November 2012